Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Gilead's oral influenza drug enters phase II

May 30, 1997

NIH sponsors ProScript's research on novel malaria treatment

May 29, 1997

Antiviral pyrimidine nucleosides described by Yamasa

May 27, 1997

Microcide reveals new cephalosporins active against resistant organisms

May 27, 1997

Orthosomycins discovered by Schering-Plough

May 26, 1997

AmBisome cleared for marketing in Brazil

May 23, 1997

Fluconazole safe and effective for tinea corporis/cruris

May 23, 1997

Antiplatelet effects of arbidol

May 22, 1997

Isis reports positive safety and efficacy profile for fomivirsen

May 22, 1997

Rhone-Poulenc Rorer launches Zagam in the U.S.

May 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...